Blog
Provocholine®
Aridol®
Partnerships
Training
Clinical Research Consultation
CRCE Courses
Blogs / Podcast
Guidelines / Publications
Speaking Engagements
Welcome to Our Blog
Methapharm Respiratory is proud to work with healthcare practitioners to support the right diagnosis for patients exhibiting common respiratory symptoms such as cough, wheeze, and shortness of breath. We are a trusted partner for bronchoprovocation testing, supplying Provocholine and Aridol. We also offer training and education (CRCE) at no cost.
This blog is intended to be an additional resource to the education Methapharm currently offers through the American Association for Respiratory Care (AARC) and the Canadian Society of Respiratory Therapists (CSRT) approved CRCEs. While this blog will not provide education credits, it will explore current issues and interesting topics relevant to readers’ day-to-day work and personal lives. We hope that you will investigate further any of the topics we cover here. Please join us monthly as we share respiratory-related topics and beyond.
September Surge: Asthma Action Plans
Back-to-school season is a well-documented peak period for asthma exacerbations. Exacerbations typically begin increasing in early September, peak around the third week of the month, and gradually decline thereafter. This seasonal rise is associated with several...
Recent Posts
September Surge: Asthma Action Plans
Back-to-school season is a well-documented peak period for asthma exacerbations. Exacerbations typically begin increasing in early September, peak around the third week of the month, and gradually decline thereafter. This seasonal rise is associated with several...
Case Study – Objective Testing for Confirming Asthma
Objective testing is the foundation of accurate asthma diagnosis and effective long-term management. Yet it remains underused, increasing the risk of both overtreatment and undertreatment.1 When a patient does not respond as expected, escalating medication without...
Obesity and Asthma
For many patients, asthma symptoms are not driven by airway inflammation alone. Obesity can influence lung mechanics, systemic inflammation, medication response, and overall disease burden. Asthma is a common chronic disease, affecting approximately 26 million people...